Skip to content

The Effect of Goal-directed Hemodynamic Therapy in Radical Cystectomy

The Effect of Goal-directed Hemodynamic Therapy on Clinical Outcomes in Patients Undergoing Radical Cystectomy: : A Randomized Controlled Trial

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03505112
Enrollment
82
Registered
2018-04-23
Start date
2018-04-20
Completion date
2021-10-24
Last updated
2022-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Radical Cystectomy

Keywords

Goal-directed therapy, stroke volume index

Brief summary

Goal-directed therapy (GDT) has been applied to various clinical settings and has been widely researched recently as a method for perioperative management of patients. Radical cystectomy is a complex surgical procedure in which the bladder is removed, followed by urinary diversion. It is an extensive and time-consuming intervention and has high probability of fluid imbalance and bleeding during surgery. We hypothesized that the application of GDT in these patients would improve clinical postoperative outcomes. Therefore, we will attempt to evaluate improvement of postoperative outcomes after applying GDT protocol based on changes in stroke volume index, cardiac index and mean arterial pressure in radical cystectomy.

Interventions

The patients in GDT group will receive intravenous crystalloid fluid or vasopressor or inotropic agent according to the goal-directed therapy protocol utilizing FloTrac / EV1000 clinical platform (Edwards Lifesciences, Irvine, CA, USA). After induction of anesthesia, the baseline stroke volume index (SVI) is measured and then 200-250 ml of crystalloid is administered over 5-10 minutes. If SVI increase by ≥10%, 200-250 ml of crystalloid is given repeatedly until the increase in SVI \<10%. If SVI does not increase by ≥10% and there is no decrease in mean arterial pressure (MAP), revaluate SVI every 10 minutes. Despite an increase in SVI of \<10% after fluid challenge, if a decrease in MAP is accompanied by cardiac index (CI) ≤ 2.5 L/min/m2, dobutamine is administered by continuous infusion. If there is a decrease in MAP but no decrease in CI, start low dose norepinephrine continuous infusion.

Sponsors

Seoul National University Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

Prospective, single-center, double-blind, parallel-group, randomized, controlled trial

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients undergoing open radical cystectomy * Patients with American Society of Anesthesiologists physical status I-III

Exclusion criteria

* Significant hepatic dysfunction, significant renal dysfunction (estimated glomerular filtration rate \<60 ml/min) * Congestive heart failure (New York Heart Association scores ≥3), Left Ventricular Ejection Fraction \< 35% * Arrhythmia * Coagulopathy (PT INR \>1.5)

Design outcomes

Primary

MeasureTime frameDescription
A composite of postoperative complicationsthrough the hospitalization period, an average of 2 weeksTotal incidence of postoperative complications including gastrointestinal complications, complications of infections, wound complications, cardiac events, thromboembolic complications, genitourinary complications, neurological complications based on the Clavien-Dindo classification for radical cystectomy.

Secondary

MeasureTime frameDescription
The incidence of postoperative complications of infectionsthrough the hospitalization period, an average of 2 weeksComplications of infections include urinary tract infection, sepsis, pneumonia, wound infection according to the Clavien-Dindo classification for radical cystectomy.
The incidence of postoperative wound complicationsthrough the hospitalization period, an average of 2 weeksWound Complications mean wound dehiscence diagnosed clinically and requiring resuturing, according to the Clavien-Dindo classification for radical cystectomy.
The incidence of postoperative cardiac eventsthrough the hospitalization period, an average of 2 weeksCardiac events include myocardial infarction, arrhythmia, congestive heart failure, pulmonary edema and transient brain natriuretic peptide increase (serum brain natriuretic peptide values 100-500 pg/ml) according to the Clavien-Dindo classification for radical cystectomy.
The incidence of postoperative gastrointestinal complicationsthrough the hospitalization period, an average of 2 weeksGastrointestinal complications include ileus, constipation, gastric ulcer, anastomic bowel leak according to the Clavien-Dindo classification for radical cystectomy.
The incidence of postoperative genitourinary complicationsthrough the hospitalization period, an average of 2 weeksGenitourinary complications include renal dysfunction, renal failure, urinary leakage according to the Clavien-Dindo classification for radical cystectomy.
The incidence of postoperative neurological complicationsthrough the hospitalization period, an average of 2 weeksNeurological complications mean presence of a de novo focal deficit, confusion/delirium according to the Clavien-Dindo classification for radical cystectomy.
The incidence of postoperative thromboembolic complicationsthrough the hospitalization period, an average of 2 weeksThromboembolic complication means pulmonary embolism evidenced by spiral computerized tomography scanning according to the Clavien-Dindo classification for radical cystectomy.

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 10, 2026